Condition: Cannabis use
rs10499 in
ATP2A1;RABEP2 gene and
Cannabis use
PMID 30150663 2018 GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia.
rs1574587 in
ATP2C2 gene and
Cannabis use
PMID 30003630 2018 Genome-wide association meta-analysis of age at first cannabis use.
rs1448602 in
CADM2 gene and
Cannabis use
PMID 30150663 2018 GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia.
rs1476535 in
FOXP2 gene and
Cannabis use
PMID 30610198 2019 Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality.
rs56319043 in
KDM4A-AS1;ST3GAL3;KDM4A gene and
Cannabis use
PMID 30610198 2019 Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality.
rs4916723 in
LINC00461 gene and
Cannabis use
PMID 30610198 2019 Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality.
rs139868495 in
LINC01288 gene and
Cannabis use
PMID 30610198 2019 Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality.
rs142324060 in
LOC101929710;MIR583HG gene and
Cannabis use
PMID 25987507 2015 Heritability, SNP- and Gene-Based Analyses of Cannabis Use Initiation and Age at Onset.
rs2391769 in
LOC105378866 gene and
Cannabis use
PMID 30610198 2019 Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality.
rs76545266 in
LOC105379365 gene and
Cannabis use
PMID 30610198 2019 Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality.
rs145108385 in
LOC648987 gene and
Cannabis use
PMID 30610198 2019 Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality.
rs4471463 in
NCAM1 gene and
Cannabis use
PMID 27023175 2016 Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis Consortium.
PMID 30150663 2018 GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia.
rs11210887 in
PTPRF gene and
Cannabis use
PMID 30610198 2019 Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality.
rs10085617 in
SDK1 gene and
Cannabis use
PMID 30150663 2018 GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia.
rs8039398 in
SEMA6D gene and
Cannabis use
PMID 30610198 2019 Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality.
rs113551349 in
SLC6A9 gene and
Cannabis use
PMID 30610198 2019 Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality.
rs17761723 in
SMG6 gene and
Cannabis use
PMID 30150663 2018 GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia.
rs9773390 in
ZNF704 gene and
Cannabis use
PMID 30150663 2018 GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia.